# Zinc Supplementation on Cellular Immunity in Thalassemia Major

> **NCT03117192** · PHASE4 · COMPLETED · sponsor: **Fakultas Kedokteran Universitas Indonesia** · enrollment: 58 (actual)

## Conditions studied

- Thalassemia
- Splenectomy; Status
- Immunosuppression

## Interventions

- **DRUG:** Zinc Sulfate
- **DRUG:** Sucrose Syrup

## Key facts

- **NCT ID:** NCT03117192
- **Lead sponsor:** Fakultas Kedokteran Universitas Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-01
- **Primary completion:** 2014-02-01
- **Final completion:** 2014-02-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03117192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03117192, "Zinc Supplementation on Cellular Immunity in Thalassemia Major". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03117192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*